Literature DB >> 8636453

Topical metronidazole application compared with subgingival scaling. A clinical and microbiological study on recall patients.

M Stelzel1, L Florès-de-Jacoby.   

Abstract

The aim of this study was to compare the topical application of a metronidazole 25% dental gel with subgingival scaling. 30 patients from the recall program participated in this open randomised study with split-mouth design. Pocket probing depths (PPD) and bleeding on probing (BOP) were measured before and 2, 12 and 24 weeks after the end of the treatment period. In addition, subgingival plaque samples were taken from all mesial sites and analysed with dark-field microscopy. All patients had at least 1 tooth in each quadrant with a PPD of 5 mm or more that should bleeding on probing, when entering the study. The treatment consisted of 2 applications of the dental gel in 2 randomly selected quadrants (on days 0 and 7) as well as simultaneous subgingival scaling of the remaining quadrants. Oral hygiene instruction was given on day 21. The average PPD and the average frequency of BOP were calculated for all sites with an initial PPD of 5 mm or more and continued at each examination, using the same sites. The statistical analyses showed that both treatments were effective in reducing PPD and BOP over the 6-month period. At the end of the follow-up period, the mean reduction in PPD was 1.3 mm after gel treatment and 1.5 mm after subgingival scaling. BOP was reduced by 35% and 42%, respectively. No significant differences between the 2 treatments were detected. Dark-field microscopy showed a shift toward a more healthy microflora for both treatment modalities; this persisted throughout the 6-month period. Application of a 25% metronidazole dental gel on recall patients seems to be as effective on the investigated clinical and microbiological parameters as subgingival scaling.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8636453     DOI: 10.1111/j.1600-051x.1996.tb00500.x

Source DB:  PubMed          Journal:  J Clin Periodontol        ISSN: 0303-6979            Impact factor:   8.728


  6 in total

1.  Comparative Evaluation of Azadirachta indica (Neem) Chip and Soft Tissue Diode Lasers as a Supplement to Phase I Periodontal Therapy in Localized Chronic Moderate Periodontitis: A Randomized Controlled Clinical Trial.

Authors:  Minal N Ganvir; Simran R Parwani; Dhanashree S Chaudhary; Rajkumar Parwani; Himanshu Dadlani; Ashok K Vikey; Kshipra P Kawadkar; Nishita S Jaju; Niccoló Giuseppe Armogida; Gianrico Spagnuolo
Journal:  Int J Dent       Date:  2022-06-15

2.  Comparative evaluation of locally delivered minocycline and metronidazole in the treatment of periodontitis.

Authors:  Nymphea Pandit; Ritu Dahiya; Rajan Gupta; Deepika Bali; Abhinav Kathuria
Journal:  Contemp Clin Dent       Date:  2013-01

3.  Evaluation of superoxide dismutase levels in local drug delivery system containing 0.2% curcumin strip as an adjunct to scaling and root planing in chronic periodontitis: A clinical and biochemical study.

Authors:  Sugumari Elavarasu; Thangakumaran Suthanthiran; Arthiie Thangavelu; Sanjay Alex; Vijaya Kumar Palanisamy; Tamil Selvan Kumar
Journal:  J Pharm Bioallied Sci       Date:  2016-10

4.  Amixicile, a novel strategy for targeting oral anaerobic pathogens.

Authors:  Justin A Hutcherson; Kathryn M Sinclair; Benjamin R Belvin; Qin Gui; Paul S Hoffman; Janina P Lewis
Journal:  Sci Rep       Date:  2017-09-05       Impact factor: 4.379

5.  Comparison of 1-periodontal indices and cultural porphyromonas gingivalis colony count in aggressive periodontitis patients treated by scaling and rootplanning with or without metronidazole gel.

Authors:  Z Kadkhoda; S Rafiei Tari; P Owlia; S Seyyed Zadeh Sabounchei
Journal:  J Dent (Tehran)       Date:  2012-03-31

6.  Inhibitors of bacterial protease enzymes for periodontal therapy.

Authors:  Kalid N Hosn; Mary Margaret Jefferson; Carlton Leding; Solomon Shokouh-Amiri; Edwin L Thomas
Journal:  Clin Exp Dent Res       Date:  2015-10-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.